MSTN and Obesity: Collectively, these studies and others [26, 43] point to a growing body of evidence that increased myostatin is involved in contributing to metabolic dysfunction in the skeletal muscle of obese individuals, particularly when obesity is associated with metabolic abnormalities, suggesting that it may contribute to insulin resistance [25].